Literature DB >> 15023275

Gonorrhea Update.

Margaret C. Bash1.   

Abstract

This article provides a brief summary of recent US epide-miology, antimicrobial resistance, and treatment of Neisseria gonorrhoeae infections. Selected research regarding infections caused by N. gonorrhoeae is described, with particular emphasis on the advances made by new molecular methods.

Entities:  

Year:  2004        PMID： 15023275     DOI： 10.1007/s11908-996-0009-5

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN： 1523-3847            Impact factor:   3.725


  54 in total

1.  Antimicrobial resistance of Neisseria gonorrhoeae and high prevalence of ciprofloxacin-resistant isolates in Japan, 1993 to 1998.

Authors:  M Tanaka; H Nakayama; M Haraoka; T Saika
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  STD screening, testing, case reporting, and clinical and partner notification practices: a national survey of US physicians.

Authors:  Janet S St Lawrence; Daniel E Montaño; Danuta Kasprzyk; William R Phillips; Keira Armstrong; Jami S Leichliter
Journal:  Am J Public Health       Date:  2002-11       Impact factor: 9.308

Review 3.  The role of porins in neisserial pathogenesis and immunity.

Authors:  Paola Massari; Sanjay Ram; Heather Macleod; Lee M Wetzler
Journal:  Trends Microbiol       Date:  2003-02       Impact factor: 17.079

4.  Serological classification of Neisseria gonorrhoeae with use of monoclonal antibodies to gonococcal outer membrane protein I.

Authors:  J S Knapp; M R Tam; R C Nowinski; K K Holmes; E G Sandström
Journal:  J Infect Dis       Date:  1984-07       Impact factor: 5.226

Review 5.  Recombination, repair and replication in the pathogenic Neisseriae: the 3 R's of molecular genetics of two human-specific bacterial pathogens.

Authors:  Kimberly A Kline; Eric V Sechman; Eric P Skaar; H Steven Seifert
Journal:  Mol Microbiol       Date:  2003-10       Impact factor: 3.501

6.  Acquired macrolide resistance genes in pathogenic Neisseria spp. isolated between 1940 and 1987.

Authors:  Sydney Cousin; William L H Whittington; Marilyn C Roberts
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

7.  LCR testing for gonorrhoea and chlamydia in population surveys and other screenings of low prevalence populations: coping with decreased positive predictive value.

Authors:  J M Zenilman; W C Miller; C Gaydos; S M Rogers; C F Turner
Journal:  Sex Transm Infect       Date:  2003-04       Impact factor: 3.519

8.  Duration of persistence of gonococcal DNA detected by ligase chain reaction in men and women following recommended therapy for uncomplicated gonorrhea.

Authors:  Laura H Bachmann; Renee A Desmond; Joan Stephens; Annalee Hughes; Edward W Hook
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

9.  Molecular epidemiology of endemic ciprofloxacin-resistant Neisseria gonorrhoeae in Liverpool.

Authors:  J E Corkill; A J Komolafe; T J Neal; A Mortimore; A B Alawattegama; C A Hart
Journal:  Int J STD AIDS       Date:  2003-06       Impact factor: 1.359

Review 10.  Testing for chlamydial and gonorrheal infections outside of clinic settings: a summary of the literature.

Authors:  Carol A Ford; Claire I Viadro; William C Miller
Journal:  Sex Transm Dis       Date:  2004-01       Impact factor: 2.830
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.